The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Madri Joseph A since 2007.
The trader's CIK number is 1231947.
At the time of the last reporting, Madri Joseph A was the Director of Alexion Pharmaceuticals, Inc.. (stock ticker symbol ALXN).
Also see all insider trading activities at Alexion Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2014 | ALXN | 0 | $0 | 90,000 | $15,516,900 | 90,000 | $718,500 |
| 2013 | ALXN | 0 | $0 | 30,000 | $3,450,000 | 30,000 | $166,500 |
| 2012 | ALXN | 0 | $0 | 46,000 | $4,563,920 | 49,115 | $170,840 |
| 2011 | ALXN | 0 | $0 | 48,965 | $3,456,420 | 47,725 | $280,200 |
| 2010 | ALXN | 0 | $0 | 42,000 | $2,408,210 | 42,965 | $1,417,002 |
| 2008 | ALXN | 0 | $0 | 4,000 | $152,920 | 4,000 | $23,520 |
| 2007 | ALXN | 0 | $0 | 500 | $29,492 | 2,000 | $20,760 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2014-03-11 | ALXN | Option Ex | 60,000 | 9.51 | 570,600 |
| 2014-03-11 | ALXN | Sale | 60,000 | 179.12 | 10,746,900 |
| 2014-02-07 | ALXN | Option Ex | 30,000 | 4.93 | 147,900 |
| 2014-02-07 | ALXN | Sale | 30,000 | 159.00 | 4,770,000 |
| 2013-09-16 | ALXN | Option Ex | 30,000 | 5.55 | 166,500 |
| 2013-09-16 | ALXN | Sale | 30,000 | 115.00 | 3,450,000 |
| 2012-08-03 | ALXN | Sale | 30,000 | 107.32 | 3,219,600 |
| 2012-08-03 | ALXN | Option Ex | 30,000 | 4.26 | 127,800 |
| 2012-02-28 | ALXN | Option Ex | 16,000 | 2.69 | 43,040 |
| 2012-02-28 | ALXN | Sale | 16,000 | 84.02 | 1,344,320 |
| 2012-02-03 | ALXN | Option Ex | 3,115 | .00 | 0 |
| 2011-07-27 | ALXN | Option Ex | 30,000 | 3.90 | 117,000 |
| 2011-07-27 | ALXN | Sale | 30,000 | 56.53 | 1,695,900 |
| 2011-02-17 | ALXN | Option Ex | 15,000 | 10.88 | 163,200 |
| 2011-02-17 | ALXN | Sale | 18,965 | 92.83 | 1,760,520 |
| 2011-02-02 | ALXN | Option Ex | 2,725 | .00 | 0 |
| 2010-10-29 | ALXN | Option Ex | 15,000 | 40.25 | 603,750 |
| 2010-10-29 | ALXN | Sale | 15,000 | 68.41 | 1,026,150 |
| 2010-06-14 | ALXN | Option Ex | 20,000 | 32.25 | 645,000 |
| 2010-06-14 | ALXN | Sale | 20,000 | 52.87 | 1,057,400 |
| 2010-02-16 | ALXN | Sale | 7,000 | 46.38 | 324,660 |
| 2010-02-16 | ALXN | Option Ex | 4,000 | 42.06 | 168,252 |
| 2010-01-28 | ALXN | Option Ex | 3,965 | .00 | 0 |
| 2008-10-29 | ALXN | Option Ex | 4,000 | 5.88 | 23,520 |
| 2008-10-29 | ALXN | Sale | 4,000 | 38.23 | 152,920 |
| 2007-08-21 | ALXN | Option Ex | 2,000 | 10.38 | 20,760 |
| 2007-08-21 | ALXN | Sale | 500 | 58.98 | 29,492 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Madri Joseph A (Director of Alexion Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.